← Alignment Healthcare, Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Net loss | ($44.7m) | ($22.9m) | ($195.3m) | ($149.6m) | ($148.2m) | ($128.1m) | ($978k) | |
| Net Income (Loss) Attributable to Parent | — | ($22.9m) |
($195.3m)
-751.81%
|
($149.5m)
+23.42%
|
($148.0m)
+1.02%
|
($128.0m)
+13.50%
|
($724k)
+99.43%
|
|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | ($22.9m) | ($195.3m) | ($149.6m) | ($148.2m) | ($128.1m) | ($978k) | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | $0 | ($92k) | ($156k) | ($36k) | ($254k) | |
| Depreciation, Depletion and Amortization | $16.6m | $15.1m | $15.8m | $17.3m | $21.4m | $26.9m | $30.4m | |
| Amortization of Debt Issuance Costs | — | $2.2m | $2.3m | $1.9m | — | $1.3m | $1.8m | |
| Amortization of Debt Issuance Costs and Discounts | — | — | — | — | ($3.7m) | — | — | |
| Amortization of Intangible Assets | — | $327k | $362k | $386k | $226k | $702k | $634k | |
| Depreciation | $16.6m | $15.1m | $15.7m | $17.1m | $21.4m | $26.4m | $29.8m | |
| Amortization-debt issuance costs | $1.9m | $2.2m | $2.3m | $1.9m | $1.3m | $1.3m | $1.8m | |
| Amortization-investment discount | — | — | — | $0 | ($4.9m) | ($2.6m) | ($1.3m) | |
| Share-based Payment Arrangement, Noncash Expense | — | $446k | $621k | $0 | $0 | $71.1m | $62.1m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | $350k | $0 | |
| Share-based Payment Arrangement, Expense | — | $2.1m | $122.0m | $81.7m | $66.8m | $71.1m | $62.1m | |
| Goodwill and Intangible Asset Impairment | — | $0 | $0 | $0 | $0 | $645k | $634k | |
| Nonoperating Income (Expense) | — | — | — | — | — | ($26.5m) | ($15.7m) | |
| Other Nonoperating Income (Expense) | — | ($17.7m) | ($17.2m) | ($20.7m) | ($20.4m) | $72k | $89k | |
| Changes in operating assets and liabilities: | ||||||||
| Increase (Decrease) in Accounts Receivable | — | $4.6m | $17.6m | $34.4m | $26.9m | $34.3m | $100.1m | |
| Accounts receivable | ($5.8m) | ($4.6m) | ($17.6m) | ($34.4m) | ($26.9m) | ($34.3m) | ($100.1m) | |
| Accounts payable and accrued expenses | $1.3m | $645k | $437k | $13.7m | ($6.3m) | ($1.5m) | $10.4m | |
| Acquisition of property in accounts payable | $366k | $106k | $347k | $505k | $0 | $70k | $97k | |
| Debt issuance costs in accounts payable | — | — | — | $0 | $0 | $512k | $0 | |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | — | $261.6m | $319.2m | $385.5m | $477.8m | $823.6m | $1.1b | |
| Accrued compensation | ($196k) | $12.7m | ($1.2m) | $3.6m | $6.6m | $5.8m | $9.1m | |
| Increase (Decrease) in Other Operating Assets | — | ($2.8m) | ($644k) | $86k | $142k | ($60k) | $50k | |
| Prepaid expenses and other current assets | ($2.7m) | ($12.0m) | ($10.3m) | ($14.4m) | ($2.9m) | $7.9m | ($57.1m) | |
| Other assets | $1.2m | $2.8m | $644k | ($86k) | ($142k) | $60k | ($50k) | |
| Restricted cash in other assets | $0 | $500k | $1.8m | $1.8m | $2.0m | $2.1m | $2.1m | |
| Net Cash Provided by (Used in) Operating Activities | $9.2m |
$7.6m
-17.89%
|
($78.8m)
-1141.87%
|
($45.4m)
+42.33%
|
($59.2m)
-30.29%
|
$34.8m
+158.75%
|
$139.9m
+302.44%
|
|
| Cash flows from investing activities: | ||||||||
| Payments to Acquire Property, Plant, and Equipment | — | — | — | — | — | $41.4m | $26.8m | |
| Gain (Loss) on Disposition of Property Plant Equipment | $0 | ($1.0m) | $0 | ($101k) | $0 | $0 | $72k | |
| Payments to Acquire Investments | — | $1.6m | $2.5m | $2.8m | $379.1m | $82.2m | $65.6m | |
| Purchase of investments | ($320k) | ($1.6m) | ($2.5m) | ($2.8m) | ($379.1m) | ($82.2m) | ($65.6m) | |
| Maturities of investments | — | — | — | $2.4m | $267.8m | $162.8m | $76.3m | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | $0 | $0 | — | — | |
| Net Cash Provided by (Used in) Investing Activities | ($10.2m) | ($16.4m) | ($20.8m) | ($28.2m) | ($147.3m) | $39.2m | ($15.0m) | |
| Cash flows from financing activities: | ||||||||
| Repayments of Long-term Debt | — | — | — | $143.2m | $0 | $215.0m | $0 | |
| Proceeds from Issuance of Long-term Debt | — | $0 | $0 | $165.0m | $0 | $380.0m | $0 | |
| Gain (Loss) on Extinguishment of Debt | — | — | — | ($2.2m) | $0 | ($3.0m) | $0 | |
| Loss on extinguishment of debt | — | $0 | $0 | $2.2m | $0 | $3.0m | $0 | |
| Proceeds from long-term debt | $55.0m | $0 | $0 | $165.0m | $0 | $380.0m | $0 | |
| Debt issuance costs | ($854k) | $0 | $0 | ($5.2m) | $0 | ($8.8m) | ($26k) | |
| Repayment of long-term debt | — | $0 | $0 | ($143.2m) | $0 | ($215.0m) | $0 | |
| Proceeds from Issuance of Common Stock | — | $135.0m | $390.6m | $0 | $0 | — | — | |
| Net Cash Provided by (Used in) Financing Activities | $52.7m |
$130.1m
+147.08%
|
$360.1m
+176.76%
|
$16.6m
-95.39%
|
$105k
-99.37%
|
$156.0m
+148498.10%
|
$18.0m
-88.44%
|
|
| Net increase (decrease) in cash | $51.6m | $121.3m | $260.5m | ($57.1m) | ($206.3m) | $230.0m | $143.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | — | $230.0m | $143.0m | |
| Cash, cash equivalents and restricted cash at beginning of period | $86.5m | $207.8m | $468.4m | $411.3m | $205.0m | $434.9m | $577.9m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $207.8m | $468.4m | $411.3m | $205.0m | $434.9m | $577.9m | |
| Additional Supplementary Disclosures | ||||||||
| Additional Supplementary Disclosures | ||||||||
| Additional Supplementary Disclosures | ||||||||
| Supplemental disclosure of cash flow information: | ||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $9.5m | $10.7m | $11.0m | $22.4m | $19.2m | $22.2m | $13.8m | |
| Income Taxes Paid, Net | — | — | — | — | — | — | $25k | |
| Additional Financial Items | ||||||||
| Goodwill | — | $29.3m | $29.3m | $34.8m | $34.8m | $34.8m | $32.1m | |
| Income Tax Expense (Benefit) | — | $0 | $0 | $339k | ($22k) | $21k | $20k | |
| Interest Expense Nonoperating | — | — | — | — | — | $23.5m | $15.8m | |
| Operating Expenses | — | $964.5m | $1.3b | $1.6b | $2.0b | $2.8b | $3.9b | |
| Proceeds from Noncontrolling Interests | — | — | — | $68k | $105k | $15k | $0 | |
| Proceeds from (Payments to) Noncontrolling Interests | — | $0 | $15k | — | — | — | — | |
| Proceeds from Stock Options Exercised | — | — | — | — | — | $155k | $18.1m | |
| Provision for credit loss | $1.4m | $118k | $111k | $150k | $91k | $123k | $833k | |
| (Gain) loss on right of use assets | — | — | $0 | $510k | ($289k) | $143k | $0 | |
| Equity-based compensation | — | — | — | $81.7m | $66.8m | $71.1m | $62.1m | |
| Non-cash lease expense | $0 | $2.3m | $2.7m | $2.8m | $2.3m | $1.8m | $1.6m | |
| Medical expenses payable | $36.6m | $6.5m | $12.5m | $44.2m | $35.3m | $84.4m | $184.8m | |
| Lease liabilities | $0 | $1.3m | ($3.8m) | ($4.2m) | ($3.5m) | ($1.5m) | ($1.5m) | |
| Sale of business | — | — | — | — | $0 | $0 | $1.1m | |
| Payment of employment taxes related to release of restricted stock | — | — | — | $0 | $0 | ($350k) | $0 | |
| Proceeds from exercise of stock options | — | — | — | $0 | $0 | $155k | $18.1m | |
| Contributions from noncontrolling interest holders | — | $0 | $15k | $68k | $105k | $15k | $0 | |
| Cash and cash equivalents | $86.5m | $207.3m | $466.6m | $409.5m | $202.9m | $432.9m | $575.8m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.